Correlation Between Roche Holding and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roche Holding and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roche Holding and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roche Holding AG and Novartis AG, you can compare the effects of market volatilities on Roche Holding and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roche Holding with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roche Holding and Novartis.

Diversification Opportunities for Roche Holding and Novartis

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Roche and Novartis is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Roche Holding AG and Novartis AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG and Roche Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roche Holding AG are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG has no effect on the direction of Roche Holding i.e., Roche Holding and Novartis go up and down completely randomly.

Pair Corralation between Roche Holding and Novartis

Assuming the 90 days trading horizon Roche Holding AG is expected to under-perform the Novartis. But the stock apears to be less risky and, when comparing its historical volatility, Roche Holding AG is 1.18 times less risky than Novartis. The stock trades about -0.38 of its potential returns per unit of risk. The Novartis AG is currently generating about -0.23 of returns per unit of risk over similar time horizon. If you would invest  9,981  in Novartis AG on August 27, 2024 and sell it today you would lose (613.00) from holding Novartis AG or give up 6.14% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Roche Holding AG  vs.  Novartis AG

 Performance 
       Timeline  
Roche Holding AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's technical and fundamental indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.
Novartis AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Roche Holding and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roche Holding and Novartis

The main advantage of trading using opposite Roche Holding and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roche Holding position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Roche Holding AG and Novartis AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets